Nonnucleoside Reverse Transcriptase Inhibitor Pharmacokinetics in a Large Unselected Cohort of HIV-Infected Women (vol 50, pg 482, 2009)

被引：0
|
作者：
Gandhi
机构：
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2011年 / 58卷 / 04期
关键词：
D O I：
10.1097/QAI.0b013e31823e4ead
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [21] Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance? (vol 22, pg 989, 2008)
    Scott, C.
    Grover, D.
    Nelson, M.
    AIDS, 2008, 22 (14) : I - I
  • [22] Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs
    Moore, RD
    Keruly, JC
    Chaisson, RE
    AIDS, 2001, 15 (05) : 617 - 620
  • [23] Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients
    Fatkenheuer, G
    Theisen, A
    Rockstroh, J
    Grabow, T
    Wicke, C
    Becker, K
    Wieland, U
    Pfister, H
    Reiser, M
    Hegener, P
    Franzen, C
    Schwenk, A
    Salzberger, B
    AIDS, 1997, 11 (14) : F113 - F116
  • [24] HUMAN PHARMACOKINETICS AND TOLERABILITY OF L-697,639, A NONNUCLEOSIDE HIV-1 REVERSE-TRANSCRIPTASE INHIBITOR
    VANHECKEN, A
    DEPRE, M
    DELEPELEIRE, I
    LASKIN, O
    AU, T
    WOOLF, E
    YEH, KC
    DESCHEPPER, PJ
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 1994, 14 (02) : 45 - 50
  • [25] Nonnucleoside reverse transcriptase inhibitor resistance among antiretroviral-naive HIV-positive pregnant women
    Juethner, SN
    Williamson, C
    Ristig, MB
    Tebas, P
    Seyfried, W
    Aberg, JA
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (02) : 153 - 156
  • [26] Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1 (vol 97, pg 4228, 2008)
    Gupta, Kavita M.
    Pearce, Serena M.
    Poursaid, Azadeh E.
    Aliyar, Hyder A.
    Tresco, Patrick A.
    Mitchnik, Mark A.
    Kiser, Patrick F.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (03) : 1199 - 1199
  • [27] An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients
    D'Avolio, Antonio
    Baietto, Lorena
    Siccardi, Marco
    Sciandra, Mauro
    Simiele, Marco
    Oddone, Valentina
    Bonora, Stefano
    Di Perri, Giovanni
    THERAPEUTIC DRUG MONITORING, 2008, 30 (06) : 662 - 669
  • [28] The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults
    Mackie, Nicola E.
    Dunn, David T.
    Dolling, David
    Garvey, Lucy
    Harrison, Linda
    Fearnhill, Esther
    Tilston, Peter
    Sabin, Caroline
    Geretti, Anna M.
    AIDS, 2013, 27 (14) : 2245 - 2253
  • [29] Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects
    Bongiovanni, Marco
    Fausto, Alfonso
    Cicconi, Paola
    Aliprandi, Alberto
    Cornalba, Giampaolo
    Bini, Teresa
    Sardanelli, Francesco
    D'Arminio Monforte, Antonella
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (02) : 485 - 486
  • [30] Use of Nucleoside Reverse Transcriptase Inhibitor-only Regimens in HIV-infected Children and Adolescents
    Neely, Michael
    Rutstein, Richard
    Del Bianco, Gabriela
    Heresi, Gloria
    Barton, Theresa
    Wiznia, Andrew
    Wiegand, Ryan
    Wheeling, Travis
    Bohannon, Beverly
    Dominguez, Kenneth
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (09) : E370 - E376
12345